Drug Watch. Non-small-cell lung cancer.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 552
- Publication type:
- Article
Works matching IS 1082801X AND DT 2011 AND VI 46 AND IP 12
Results: 18
1
2
Meeting Coverage. Specialty drug approvals on the rise in 2011.
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
3
Meeting Coverage. Aliskiren + losartan may lower UACR equally across different levels of albuminuria.
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
4
Meeting Coverage. Long-term losartan in children with chronic kidney disease effective, safe against proteinuria.
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
5
Meeting Coverage. Tofacitinib induced responses in patients with RA refractory to TNF inhibitors.
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
6
Meeting Coverage. Mobile technology poised to redefine healthcare management.
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
7
Policy Watch. FDA promotes innovation, access to medicines while modernizing operations.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 550
- By:
- Publication type:
- Article
8
FDA mandates enhanced safety check on TNF blockers.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 546
- Publication type:
- Article
9
Bivalirudin associated with lower risk of bleeding compared to other antithrombotics in PCI.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 546
- Publication type:
- Article
10
Social media helps health plans facilitate learning, promote credibility.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 509
- By:
- Publication type:
- Article
11
Treatment of rheumatoid arthritis: A review of recommendations and emerging therapy.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 532
- By:
- Publication type:
- Article
12
Focus on 2011: A year of novel pharmacologic agents in review.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 516
- Publication type:
- Article
13
High Court to rule on health reform legality.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 510
- By:
- Publication type:
- Article
14
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 507
- Publication type:
- Article
15
Payers rein in multiple sclerosis drug costs as oral agent prices soar.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 509
- By:
- Publication type:
- Article
16
FDA Drug Approvals. New molecular entities.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 507
- Publication type:
- Article
17
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 508
- Publication type:
- Article
18
FDA Drug Approvals. First-time generic approval.
- Published in:
- Formulary, 2011, v. 46, n. 12, p. 508
- Publication type:
- Article